Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy: a Multicenter Validation of Clinical Decision Rule

NCT03434795 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT03434795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03434795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy: a Multicenter Validation of Clinical Decision Rule
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
May 31, 2017
Enrollment
1,900 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

febrile neutropenia, rule of clinical decision, chemotherapy